AI assistant
BIO-TECHNE Corp — Director's Dealing 2024
Aug 19, 2024
30718_dirs_2024-08-19_af933030-9b75-41fb-9435-db39178c3792.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2024-08-15
Reporting Person: Hippel James (CFO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-08-15 | Performance Restricted Stock Units | $ | A | 24062 | Acquired | Common Stock (24062) | Direct | |
| 2024-08-15 | Restricted Stock Units | $ | A | 12031 | Acquired | Common Stock (12031) | Direct | |
| 2024-08-15 | Stock Options (Right to Buy) | $74.91 | A | 32417 | Acquired | 2034-08-15 | Common Stock (32417) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 99926 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Options (Right to Buy) | $31.26 | 2024-08-09 | Common Stock (53867) | 53867 | Direct |
| Stock Options (Right to Buy) | $44.33 | 2025-08-08 | Common Stock (168620) | 168620 | Direct |
| Stock Options (Right to Buy) | $47.60 | 2026-08-07 | Common Stock (186068) | 186068 | Direct |
| Stock Options (Right to Buy) | $66.97 | 2027-08-05 | Common Stock (167328) | 167328 | Direct |
| Stock Options (Right to Buy) | $120.46 | 2028-08-06 | Common Stock (40536) | 40536 | Direct |
| Performance Restricted Stock Units | $ | Common Stock (10912) | 10912 | Direct | |
| Performance Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (33916) | 33916 | Direct |
| Stock Options (Right to Buy) | $94.52 | 2029-08-15 | Common Stock (45220) | 45220 | Direct |
| Performance Restricted Stock Units | $ | Common Stock (13865) | 13865 | Direct | |
| Performance Stock Options (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (37314) | 37314 | Direct |
| Stock Options (Right to Buy) | $84.61 | 2030-08-15 | Common Stock (45923) | 45923 | Direct |
| Restricted Stock Units | $ | Common Stock (26318) | 26318 | Direct |
Footnotes
F1: Fully exercisable.
F2: Options to purchase 10,134 shares vest on each of 8/6/2022, 8/6/2023, 8/6/2024 and 8/6/2025.
F3: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne Corporation common stock.
F4: Vests in full or in part on 8/15/2025 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F5: Options to purchase 11,305 shares vest on each of 8/15/2023, 8/15/2024, 8/15/2025 and 8/15/2026.
F6: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F7: Options to purchase 11,481 shares vest on each of 8/15/2024, 8/15/2025 and 8/15/2027, and options to purchase 11,480 shares vest on 8/15/2026.
F8: 13,159 restricted stock units vest on each of 11/1/2024 and 11/1/2025.
F9: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).
F10: 4,010 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 4,011 restricted stock units vest on 8/15/2027.
F11: Options to purchase 8,104 shares vest on each of 8/15/2025, 8/15/2026 and 8/15/2027, and options to purchase 8,105 shares vest on 8/15/2028.